SCHEDULE 13G/A: Wolverine Entities Disclose 7.25% Passive Stake in Aimei Health Technology

Wolverine Asset Management LLC and its affiliated entities have filed an amended Schedule 13G, reporting a passive beneficial ownership of 7.25% in Aimei Health Technology Co., Ltd.'s Ordinary Shares as of December 31, 2024.

Summary

• Wolverine Asset Management LLC, Wolverine Trading Partners, Inc., Wolverine Holdings, L.P., Christopher L. Gust, and Robert R. Bellick collectively reported beneficial ownership of 654,039 Ordinary Shares of Aimei Health Technology Co., Ltd.
• This ownership represents 7.25% of the Issuer's outstanding Ordinary Shares.
• The percentage was calculated based on 9,026,000 Ordinary Shares outstanding as of November 13, 2024, as reported in Aimei Health Technology's Form 10-Q for September 30, 2024.
• Wolverine Asset Management LLC (WAM) is an investment adviser with shared voting and disposition power over the shares.
• Wolverine Holdings, L.P. is the sole member and manager of WAM.
• Robert R. Bellick and Christopher L. Gust control Wolverine Trading Partners, Inc., which is the general partner of Wolverine Holdings.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
• Wolverine Flagship Fund Trading Limited is known to have the right to receive dividends or proceeds from the sale of these shares.

Sentiment

Score: 5

Explanation: Neutral. The document is a factual disclosure of a passive ownership stake, providing no positive or negative sentiment regarding the company's performance or outlook.

Positives

• A significant institutional investor, Wolverine Asset Management and its affiliates, holds a substantial 7.25% stake, indicating their confidence in Aimei Health Technology as a passive investment.

Risks

• The filing explicitly states that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control, meaning this investor is not expected to drive strategic changes or activist initiatives.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the issuer's future performance or the reporting persons' future investment intentions beyond the passive nature of the current holding.

Industry Context

This filing is a routine disclosure of a passive investment stake by an asset management firm in a publicly traded company. It does not provide specific insights into broader industry trends within the health technology sector, but rather reflects an investment decision by a financial entity.

Related Party Transactions

• Wolverine Asset Management, LLC is an investment adviser whose sole member and manager is Wolverine Holdings, L.P.
• Wolverine Trading Partners, Inc. is the general partner of Wolverine Holdings, L.P., and is controlled by Robert R. Bellick and Christopher L. Gust.
• Wolverine Flagship Fund Trading Limited is known to have the right to receive dividends or proceeds from the sale of the shares beneficially owned by WAM.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant passive institutional investor's stake in the company, which can be viewed as a vote of confidence in the company's long-term value.

Key Dates

Keywords

Aimei Health Technology, Wolverine Asset Management, Schedule 13G, Beneficial Ownership, Passive Investment, Ordinary Shares, SEC Filing, Institutional Investor